Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04408638
Title A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hoffmann-La Roche

diffuse large B-cell lymphoma



Gemcitabine + Oxaliplatin + Rituximab

Gemcitabine + Oxaliplatin + RO7082859

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DEU | BEL

No variant requirements are available.